非编码RNA的CRISPR介导沉默:一种新的前列腺癌治疗方法
Mobina Tabibian1, Soudeh Ghafouri-Fard1
1Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Pathology, research and practice
|November 8, 2024
概括
非编码RNA驱动前列腺癌. 克里斯普尔/Cas9技术为控制这些癌基因提供了新的途径,有可能改善侵袭和转移的治疗方法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 非编码RNA在前列腺癌的发展中起作用.
- 一些非编码RNAs作为瘤基因起作用,促进癌症生长.
- 这些瘤基因是前列腺癌的潜在治疗点.
研究的目的:
- 审查调节非编码RNA表达的最新进展.
- 探索CRISPR/Cas9技术在前列腺癌研究中的应用.
- 突出CRISPR/Cas9在向致癌性非编码RNA中的潜力.
主要方法:
- 用CRISPR/Cas9进行非编码RNA调制的研究的文献综述.
- 关注前列腺癌模型中的应用.
- 对CRISPR/Cas9在向瘤基因中的有效性进行分析.
主要成果:
- 通过CRISPR/Cas9,可以精确控制非编码RNA的表达.
- 这项技术可以影响前列腺癌的特征,如入侵和转移.
- 针对致癌性非编码RNA的新策略正在出现.
结论:
- CRISPR/Cas9技术是调节前列腺癌中非编码RNA的一个有前途的工具.
- 使用CRISPR/Cas9针对瘤性非编码RNA可能会提供新的治疗途径.
- 需要进一步的研究来将这些发现转化为临床应用.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K
CRISPR
49.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


